Search Results - V. S. Apollonova
- Showing 1 - 5 results of 5
-
1
MicroRNA-dependent mechanisms of taxane resistance in breast cancer by V. S. Apollonova, E. I. Sidina, E. V. Tkachenko, A. V. Malek
Published 2022-12-01
Article -
2
-
3
Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases by G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, E. E. Topuzov, R. M. Paltuev, K. Yu. Zernov, V. S. Apollonova, S. S. Ereshchenko, A. V. Petrova, E. K. Zhil’tsova, O. A. Ivanova
Published 2016-06-01
Article -
4
NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER by V. F. Semiglazov, V. V. Semiglazov, G. A. Dashyan, P. V. Krivorotko, V. G. Ivanov, E. K. Zhiltsova, R. M. Paltuev, L. M. Bershtein, T. Yu. Semiglazova, S. S. Yerechshenko, V. V. Klimenko, V. S. Apollonova, A. V. Komyahov, A. A. Bessonov
Published 2018-07-01
Article -
5
Improving treatment outcomes for patients with HER2‑positive breast cancer using neoadjuvant double HER2 blockade by V. F. Semiglazov, N. B. Bekkeldieva, P. V. Krivorotko, A. V. Komyakhov, R. M. Paltuev, A. I. Tseluyko, L. P. Gigolaeva, T. T. Tabagua, E. K. Zhiltsova, V. S. Apollonova, G. A. Dashyan, A. G. Kudaybergenova, V. G. Ivanov, A. A. Bozhok, D. G. Ulrikh, A. O. Gorina, T. Yu. Semiglazova
Published 2024-11-01
Article